IntelGenx Technologies Corp. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 23 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-08-28: Reporting owner Godin Andre; Form 4; Security Options Right to Buy p.v. 0.00001; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-08-28: Reporting owner Godin Andre; Form 4; Security Options Right to Buy p.v. 0.00001; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-08-28: Reporting owner Godin Andre; Form 4; Security Options Right to Buy p.v. 0.00001; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-08-28: Reporting owner Godin Andre; Form 4; Security Options Right to Buy p.v. 0.00001; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-08-28 | Godin Andre Officer (EVP & CFO) | 4 | Options Right to Buy p.v. 0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,992 614,992 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-08-28 | Godin Andre Officer (EVP & CFO) | 4 | Options Right to Buy p.v. 0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,993 629,985 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-08-28 | Godin Andre Officer (EVP & CFO) | 4 | Options Right to Buy p.v. 0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,992 644,977 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-08-28 | Godin Andre Officer (EVP & CFO) | 4 | Options Right to Buy p.v. 0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,993 659,970 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-08-28 | Matzen Dana Officer (VP Business Development) | 4 | Options Right to Buy p.v. 00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,992 114,992 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-08-28 | Matzen Dana Officer (VP Business Development) | 4 | Options Right to Buy p.v. 00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,993 179,985 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-08-28 | Matzen Dana Officer (VP Business Development) | 4 | Options Right to Buy p.v. 00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,992 194,977 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-08-28 | Matzen Dana Officer (VP Business Development) | 4 | Options Right to Buy p.v. 00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,993 259,970 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-08-28 | Zerbe Horst G Director, Officer (President & CEO) | 4 | Options right to buy common stock (0.00001 par value) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,977 69,977 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-08-28 | Zerbe Horst G Director, Officer (President & CEO) | 4 | Options right to buy common stock (0.00001 par value) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,977 114,954 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-08-28 | Zerbe Horst G Director, Officer (President & CEO) | 4 | Options right to buy common stock (0.00001 par value) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,977 159,931 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-08-28 | Zerbe Horst G Director, Officer (President & CEO) | 4 | Options right to buy common stock (0.00001 par value) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,977 204,908 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-08-28 | Paiement Nadine Officer (VP Research and Development) | 4 | Options Right to buy (p.v. 0.0001) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,992 89,992 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-08-28 | Paiement Nadine Officer (VP Research and Development) | 4 | Options Right to buy (p.v. 0.0001) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,993 104,985 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-08-28 | Paiement Nadine Officer (VP Research and Development) | 4 | Options Right to buy (p.v. 0.0001) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,992 119,977 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-08-28 | Paiement Nadine Officer (VP Research and Development) | 4 | Options Right to buy (p.v. 0.0001) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,993 134,970 owned after | $0.77 exercise price | 2017-08-30 | |
| 2017-06-13 | Paiement Nadine Officer (VP R&D) | 4 | Options (Right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 75,000 owned after | $0.51 exercise price | 2017-06-26 | |
| 2017-01-18 | Boudreau Bernard Director | 4 | (Option) right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 210,000 owned after | $0.89 exercise price | 2017-01-19 | |
| 2017-01-18 | Melchers Bernd Josef Director | 4 | Options (Right to buy) p.v. 0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 175,000 owned after | $0.89 exercise price | 2017-01-19 | |
| 2017-01-18 | Nawacki Mark Director | 4 | Options (Right to Buy) P.V. 0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 125,000 owned after | $0.89 exercise price | 2017-01-19 | |
| 2017-01-18 | Mayr Clemens Director | 4 | Options (Right to buy) p.v. 0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 175,000 owned after | $0.89 exercise price | 2017-01-19 | |
| 2017-01-18 | Marinucci John Director | 4 | Options (Right to buy) p.v. 0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 150,000 owned after | $0.89 exercise price | 2017-01-19 | |
| 2017-01-18 | Troup John Archibald Director | 4 | Options (Right to buy) P.V. 0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 250,000 owned after | $0.89 exercise price | 2017-01-19 |